Carbohydrate-derived fulvic acid (CHD-FA) inhibits carrageenan-induced inflammation and enhances wound healing: Efficacy and toxicity study in rats

Drug Development Research

Volumn 73, Issue 1, 2012, Pages 18-23

  Sabi, Riaz ^a   Very, Pieter ^a   Van Rensburg, Constance E Jansen ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Anti inflammatory; Carrageenan; CHD FA; Fulvic acid; Wound healing

Indexed keywords

CARBOHYDRATE; CARBOHYDRATE DERIVED FULVIC ACID; CARRAGEENAN; CETOMICROGOL; FULVIC ACID; FUSIDIC ACID; INDOMETACIN; NONIONIC SURFACTANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; FERTILIZATION; INFLAMMATION; MOUSE; NONHUMAN; PAW EDEMA; PH; PREGNANCY; RAT; STAPHYLOCOCCUS INFECTION; TERATOGENICITY; TOXICITY TESTING; WOUND HEALING; WOUND INFECTION;

EID: 84857761316     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20445     Document Type: Article

References (17)

1. Bergh JJ, Cronje IJ, Dekker J, Dekker TG, Gerritsma LM, Mienie LJ. 1997. Non-catalytic oxidation of water-slurried coal with oxygen: identification of fulvic acids and acute toxicity. Fuel 76:149-154. (Pubitemid 127416427)
2. Dekker J, Medlen CE. 1999. Fulvic acid and its use in the treatment of various conditions. Patent Corporation Application no. PTC/IB/ 9901649.
3. Goel RK, Benerjee RS, Acharya SB. 1990. Antiulcerogenic and antiinflammatory studies with Shiligit. J Ethnopharmacol 29:95-103.
4. Jansen S, Paciolla M, Ghabbour E, Davies G, Jarnum JM. 1996. The role of metal complexation in the solubility and stability of humic acid. Materials Sci Engineering 4:181-187. (Pubitemid 126384050)
5. Kleinschmidt J. 1988. Moortherapie bei rheumatischen Erkrankungen. In: Flaig W, Goecke C. Kauffels W, editors. Moortherapie: Grundlagen und Anwendungen. Wien-Berlin: Ueberreuter. p 216-224.
6. MacCarthe P. 2001. The principles of humic substances. Soil Sci 166:730-751.
7. Naudé PJW, Cromarty AD, van Rensburg CEJ. 2010. Potassium humate inhibits carrageenan-induced paw oedema and a graftversus-host reaction in rats. Inflammopharmacology 18:33-39.
8. Petersson M, Wiber U, Lundeberg T, Uvanas-Moberg K. 2001. Oxycin decrease carrageenan induced inflammation in rats. Peptides 22:1479-1484. (Pubitemid 32770021)
9. Recio MC, Giner RM, Uriburu L, Manez S, Cerda M, De la Fuente JL. 2000. In vivo activity of pseudo guaianolide sesquiterpene lactones in acute and chronic inflammation. Life Sci 66:2518-2590.
10. Smith HF, Kroes BH, van den Berg AJ, van der Wal D, van den Worm E, Beukman CJ, van Dijk H, Labadie RP. 2000. Immunomodulatory and anti-inflammatory activity of Picrorhiza scrophulariiflora. J Ethnopharmacol 73:101-109.
11. Snyman JR, Dekker J, Malfeld SCK, van Rensburg CEJ. 2002. Pilot study to evaluate the safety and therapeutic efficacy of topical oxifulvic acid in atopic volunteers. Drug Dev Res 251: 1-4.
12. Van Beneden G. 1971. Les matiè res organiques dans les eaux et les agents de alnéothérapie. Presse Therm Clim 108:195-204.
13. Van Rensburg CEJ, van Straten A, Dekker J. 2000. An in vitro investigation of the antimicrobial activity of oxifulvic acid. J Antimicrob Chemother 46:835-854.
14. Van Rensburg CEJ, Malfeld SCK, Dekker J. 2001. Topical application of oxifulvic acid suppresses the cutaneous immune response in mice. Drug Dev Res 53:29-32. (Pubitemid 32738259)
15. Van Rensburg CEJ, Snyman JR, Mokoele T, Cromarty AD. 2007. Brown coal derived humate inhibits contact hypersensitivity; an efficacy, toxicity and teragenicity study in rats. Inflammation 30: 148-152. (Pubitemid 47573143)
16. Van Rensburg CEJ, Gandy JJ, Snyman JR. 2009. An observational trial: patent profile of users of Secomet V®. SA Fam Pract 52:165.
17. Wang C, Wang Z, Peng A, Hou J, Xin W. 1996. Interaction between fulvic acids of different origins and active oxygen radicals. Sci China C Life Sci 39:267-275. (Pubitemid 126468000)